Perspective Articles

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021

Tufts University Medical Center, Boston, MA, USA; University of Buckingham Medical School, Buckingham
MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Orbassano University Hospital, Turin
University of California Irvine, Irvine, CA
Frederick Hutchinson Cancer Research Center, Seattle, WA
Vol. 106 No. 7 (2021): July, 2021 https://doi.org/10.3324/haematol.2020.267252